Evaluating Salivary Inflammatory Biomarkers as a Non-Invasive Diagnostic Tool for Predicting the Severity of Periodontal Inflammation Introduction Periodontitis is a common inflammatory disease affecting the supporting structures of the teeth, including the gingiva, the periodontal ligament, and the alveolar bone. Its progression can lead to a loss of clinical attachment and the resorption of supporting bone, potentially resulting in tooth mobility or tooth loss in advanced cases. Early diagnosis and the assessment of the severity of inflammation are fundamental to developing an appropriate treatment plan and minimizing future complications. Salivary Inflammatory Biomarkers Saliva serves as an important biological medium containing a variety of proteins, as well as immune and inflammatory molecules, which can reflect changes occurring within oral tissues. Inflammatory biomarkers have garnered increasing attention in periodontal research due to their potential utility in assessing inflammatory activity and monitoring the response to treatment. Prominent examples of these biomarkers include Interleukin-1 beta (IL-1β), Interleukin-6 (IL-6), and Tumor Necrosis Factor-alpha (TNF-α), as well as the enzyme Matrix Metalloproteinase-8 (MMP-8), which is associated with collagen degradation and the destruction of supporting tissues. Studies have shown that the levels of certain markers may be elevated in individuals with periodontitis; however, their diagnostic accuracy varies depending on the specific marker used, the measurement method, and the clinical characteristics of the patients. The Role of Saliva in Non-Surgical Diagnosis Collecting saliva samples is simple, painless, and can be repeated during clinical visits, making it a promising option for the development of non-surgical diagnostic tools. These samples can be analyzed using specialized laboratory techniques—such as enzyme-linked immunosorbent assays (ELISA)—to determine the concentrations of inflammatory markers. When integrated with clinical examinations, these measurements can help better assess the severity of the condition and identify patients who require closer monitoring. Nevertheless, the concentrations of salivary markers can be influenced by various factors, including salivary flow rate, the timing of sample collection, oral hygiene, smoking, systemic health conditions, and other oral infections. This underscores the need for standardized procedures for sample collection and analysis. Clinical Significance and Future Challenges Despite promising findings, salivary biomarkers cannot be relied upon in isolation to determine the severity of periodontitis or to confirm a diagnosis. Clinical examination—which includes measuring periodontal pocket depth, clinical attachment level, and bleeding upon probing—along with radiographic assessment when necessary, remains fundamental to diagnosing the disease and determining its stage. It is essential to conduct large-scale clinical studies to evaluate the sensitivity and specificity of these markers, establish appropriate diagnostic thresholds, and verify their ability to predict future disease progression—rather than merely reflecting existing inflammation. Conclusion The assessment of inflammatory biomarkers in saliva represents a promising scientific approach toward more accessible diagnosis and more precise monitoring of periodontal diseases. The development and clinical validation of these techniques are expected to support therapeutic decision-making, facilitate early detection, and improve the quality of oral healthcare—while serving as a supplementary tool to clinical examination and comprehensive diagnosis.